No Data
No Data
Express News | Pasithea Therapeutics Announces Appointment of DR. Rebecca Brown to Its Scientific Advisory Board
Pasithea Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
10-Q: Q2 2024 Earnings Report
Express News | Pasithea Therapeutics Announces Completion of Enrollment and Initial Dosing of Cohort 2 Following Positive Safety Review Committee (Src) Recommendation for Pas-004 in Ongoing Phase 1 Clinical Trial
Pasithea Therapeutics to Present New Preclinical Data Showing PAS-004 Strongly Inhibits NRAS Cancer Cell Lines and Demonstrates Superior Activity in Xenograft Studies at 2024 ASCO Annual Meeting
10-Q: Q1 2024 Earnings Report
No Data
No Data